Ekso Bionics (NASDAQ:EKSO) Coverage Initiated at StockNews.com

Analysts at StockNews.com initiated coverage on shares of Ekso Bionics (NASDAQ:EKSOGet Free Report) in a note issued to investors on Wednesday. The brokerage set a “hold” rating on the stock.

Several other research firms have also weighed in on EKSO. Lake Street Capital lowered their target price on shares of Ekso Bionics from $2.50 to $2.00 and set a “buy” rating for the company in a research note on Tuesday, October 29th. HC Wainwright reaffirmed a “buy” rating and set a $9.00 price objective on shares of Ekso Bionics in a research report on Tuesday, January 14th.

Read Our Latest Stock Analysis on EKSO

Ekso Bionics Stock Performance

Shares of EKSO stock opened at $0.65 on Wednesday. The stock has a market capitalization of $14.28 million, a price-to-earnings ratio of -1.00 and a beta of 1.47. Ekso Bionics has a one year low of $0.50 and a one year high of $2.49. The company’s 50-day simple moving average is $0.67 and its 200-day simple moving average is $0.94. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.14 and a current ratio of 2.81.

Ekso Bionics (NASDAQ:EKSOGet Free Report) last released its earnings results on Monday, October 28th. The company reported ($0.10) EPS for the quarter, missing analysts’ consensus estimates of ($0.08) by ($0.02). Ekso Bionics had a negative return on equity of 83.09% and a negative net margin of 62.95%. The firm had revenue of $4.13 million for the quarter, compared to the consensus estimate of $6.00 million. During the same period in the prior year, the business earned ($0.24) EPS. Equities analysts anticipate that Ekso Bionics will post -0.48 earnings per share for the current fiscal year.

Ekso Bionics Company Profile

(Get Free Report)

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.

Featured Stories

Receive News & Ratings for Ekso Bionics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekso Bionics and related companies with MarketBeat.com's FREE daily email newsletter.